0000905718-20-000595.txt : 20200618
0000905718-20-000595.hdr.sgml : 20200618
20200618160902
ACCESSION NUMBER: 0000905718-20-000595
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200616
FILED AS OF DATE: 20200618
DATE AS OF CHANGE: 20200618
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: EMSTER KURT VON
CENTRAL INDEX KEY: 0001252524
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39323
FILM NUMBER: 20972570
MAIL ADDRESS:
STREET 1: 601 GATEWAY BOULEVARD
STREET 2: SUITE 350
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vaxcyte, Inc.
CENTRAL INDEX KEY: 0001649094
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 464233385
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 353 HATCH DR
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
BUSINESS PHONE: 650-837-0111
MAIL ADDRESS:
STREET 1: 353 HATCH DR
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
FORMER COMPANY:
FORMER CONFORMED NAME: SutroVax, Inc.
DATE OF NAME CHANGE: 20150724
4
1
vaxcyte_fm4jun1620.xml
X0306
4
2020-06-16
0
0001649094
Vaxcyte, Inc.
PCVX
0001252524
EMSTER KURT VON
C/O VAXCYTE, INC.
353 HATCH DRIVE
FOSTER CITY
CA
94404
1
0
0
0
Common Stock, $0.001 par value per share
2020-06-16
4
C
0
2185415
A
2185415
I
See Footnotes
Common Stock, $0.001 par value per share
2020-06-16
4
C
0
1217074
A
3402489
I
See Footnotes
Common Stock, $0.001 par value per share
2020-06-16
4
C
0
454812
A
3857301
I
See Footnotes
Common Stock, $0.001 par value per share
2020-06-16
4
C
0
298917
A
4156218
I
See Footnotes
Common Stock, $0.001 par value per share
2020-06-16
4
P
0
12500
16.00
A
4168718
I
See Footnotes
Series A Preferred Stock
2020-06-16
4
C
0
2185415
0
D
Common Stock, $0.001 par value per share
2185415
0
I
See Footnotes
Series B Preferred Stock
2020-06-16
4
C
0
1217074
0
D
Common Stock, $0.001 par value per share
1217074
0
I
See Footnotes
Series C Preferred Stock
2020-06-16
4
C
0
454812
0
D
Common Stock, $0.001 par value per share
454812
0
I
See Footnotes
Series D Preferred Stock
2020-06-16
4
C
0
298917
0
D
Common Stock, $0.001 par value per share
298917
0
I
See Footnotes
Shares are held by ABV VI. Abingworth LLP is the investment manager of ABV VI and has been delegated with all investment and dispositive power over the securities held by ABV VI. Reporting Person is a member of the investment committee of Abingworth LLP, which approves investment and voting decisions by a majority vote, and no individual member has the sole control or voting power over the shares held by ABV VI.
From time to time, the investment committee may delegate investment and voting authority over certain securities held by ABV VI to employees of Abingworth subject to the supervision and oversight of the investment committee, including any limits on such authority imposed by the investment committee in its discretion and the right of the investment committee to revoke such authority at any time. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, if any.
Each share of Series A, Series B, Series C and Series D Preferred Stock was convertible into shares of Common Stock, $0.001 par value per share ("Common Stock") on a one-for-one basis with no expiration date and automatically converted into Common Stock upon the closing of the initial public offering.
/s/ John Heard, as attorney-in-fact
2020-06-18